局部晚期直肠癌的全新辅助治疗。

IF 8.8 2区医学 Q1 MEDICINE, GENERAL & INTERNAL

Cochrane Database of Systematic Reviews Pub Date : 2025-05-14 DOI:10.1002/14651858.CD015590

Sophie Mueller, Yung-Shuo Kao, Carolin Kastner, Po-Huang Chen, Anne Hendricks, Gin Yi Lee, Franziska Koehler, Hong-Jie Jhou, Christoph-Thomas Germer, Enoch Yi-No Kang, Heidrun Janka, Ching-Liang Ho, Cho-Hao Lee, Armin Wiegering

引用次数: 0

摘要

目的：这是Cochrane综述（干预）的一个方案。目的如下：评估在局部晚期直肠癌患者中，总的新辅助治疗与标准治疗的有效性和安全性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Total neoadjuvant therapy for locally advanced rectal cancer.

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effectiveness and safety of total neoadjuvant therapy versus standard therapy in individuals with locally advanced rectal cancer.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Cochrane Database of Systematic Reviews 医学-医学：内科

CiteScore

10.60

自引率

2.40%

发文量

173

审稿时长

1-2 weeks

期刊介绍： The Cochrane Database of Systematic Reviews (CDSR) stands as the premier database for systematic reviews in healthcare. It comprises Cochrane Reviews, along with protocols for these reviews, editorials, and supplements. Owned and operated by Cochrane, a worldwide independent network of healthcare stakeholders, the CDSR (ISSN 1469-493X) encompasses a broad spectrum of health-related topics, including health services.